Virgin Atlantic Cargo targets transatlantic pharma business, but opts out of CEIV
Virgin Atlantic Cargo has pledged further investment in the pharmaceutical sector, but won’t consider IATA’s CEIV certification unless it is demanded by customers.
The carrier has already more than doubled its share of the pharma market between the UK and North America since launching its cool chain product two years ago – it is a market set to grow by 7% a year up to 2020.
The carrier is currently obtaining a Wholesale Distribution Authority (WDA) licence, explained Darren Sherlock, manager, products & partnerships, a newly created role at the carrier.
Source: The Loadstar